We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
ZD Medtech Raised Over CNY 100 Mn in Series B
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
Futurtec Adds CE MDR-Certified Knee-Replacement System to Its Orthopedic Robotics Portfolio
Futurtec(鑫君特)has received European Union Medical Device Regulation certification for its ORTHBOT X knee-replacement surgical navigation and positioning system, according to a company announcement reported by MedChina in August.
Aug 27, 2026 03:47 PM
Kanghong’s Conbercept Receives Marketing Authorization in Guyana
Kanghong Pharmaceutical (康弘药业) said its subsidiary Kanghong Bioscience had received a drug registration certificate from Guyana’s Food and Drug Department for conbercept ophthalmic injection, marketed under the brand name Lumitin (朗沐).
Aug 20, 2026 02:48 PM
The first batch of antigen testing agent boxes at the Shenzhen store of Da Shen Lin did not arrive. Wanfu biology was 19.3 yuan / time
Wantai BioPharm’s Nine-Valent HPV Vaccine Wins First Overseas Approval in Thailand
Wantai BioPharm (万泰生物) announced on Aug. 11 that the nine-valent HPV vaccine developed by its wholly owned subsidiary, Xiamen Innovax Biotech (万泰沧海), has received marketing authorization from Thailand’s Food and Drug Administration. The approval marks the vaccine’s first clearance outside China and an important step in Wantai BioPharm’s international expansion.
Aug 13, 2026 02:38 PM
Yuntianhua: the shareholder completed the reduction of 2% of the shares with the investment of Yuntianhua
Yifeng: Xiao Zaixiang, the Vice President, Intends to Sell Shares
From Paris to Shanghai: The Same Project, Two Different Views of Time
Sep 01, 2026 03:17 PM
Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors
Aug 04, 2026 11:21 AM
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Jul 31, 2026 02:44 PM